About IOMICS
IOMICS is a company based in Cambridge (United States) founded in 2013. It operates as a B2B, and SaaS. IOMICS offers products and services including Cures Accelerator and AI Drug Design Tools. IOMICS operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others.
- Headquarter Cambridge, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Iomics Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IOMICS
IOMICS offers a comprehensive portfolio of products and services, including Cures Accelerator and AI Drug Design Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for accelerating drug discovery and research through AI automation.
Tools for identifying drug targets and optimizing chemical species via machine learning.
Funding Insights of IOMICS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by IOMICS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IOMICS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Iomics Comparisons
Competitors of IOMICS
IOMICS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about IOMICS
When was IOMICS founded?
IOMICS was founded in 2013.
Where is IOMICS located?
IOMICS is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
What does IOMICS do?
IOMICS is a technology company that creates AI-driven platforms for systems and synthetic biology, focusing on drug discovery, repurposing, and polypharmacology. It uses machine learning to accelerate intelligent drug design and precision medicine, integrating with research pipelines. Based in Cambridge, MA, USA, it serves life sciences organizations through services like the Cures Accelerator platform. The company emphasizes data-driven innovation and seamless integration for clients in biotechnology and healthcare.
Who are the top competitors of IOMICS?
IOMICS's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does IOMICS offer?
IOMICS offers Cures Accelerator and AI Drug Design Tools.